Felipe Samaniego
Jain, Neeraj, Sehgal, Lalit, Davis, R. Eric, Shuttleworth, Stephen Joseph, Samaniego, Felipe
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Results of a First in Human, Dose Ascending, Phase I Study Examining the Safety and Tolerability of KA2237, an Oral PI3K p110β/δ Inhibitor in Patients with Relapsed/Refractory (R/R) B-Cell Lymphoma
Nastoupil, Loretta J., Neelapu, Sattva S, Davis, Eric, Samaniego, Felipe, Fowler, Nathan H, Westin, Jason R., Lee, Hun Ju, Wang, Michael, Hagemeister, Fredrick B., Beer, Philip, Cecil, Alexander R.L., Dow, James, McHale, Duncan, Silva, Franck, Ward, Penny, Yavari, Arash, Shuttleworth, Stephen Joseph
Published in Blood (13.11.2019)
Published in Blood (13.11.2019)
Get full text
Journal Article
Pre-Clinical Evaluation of the PI3K-p110β/δ Inhibitor KA2237 in Mantle Cell Lymphoma
Huang, Shengjian, Nastoupil, Loretta J., Guo, Hui, Bell, Taylor, Ahmed, Makhdum, Li, Carrie J, Wang, Jack, Liu, Yang, Zhang, Victoria, Kim, Caroline R, Boyle, Jordan N, Lorence, Elizabeth A, Lam, Laura T, Chen, Zhihong, Zhang, Hui, Shuttleworth, Stephen Joseph, Nomie, Krystle, Wang, Michael, Zhang, Liang
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article